Frazier Lifesciences Acquisition FY 2021: net income $4.2M

Key figures from this report

These are the numbers Frazier Lifesciences Acquisition reported for the year ended Dec 31, 2021, as tagged in the filing’s XBRL data, each against the year before. A plain-English reading of this report is not written yet.

1. Net income$4.2MNo year-earlier figure tagged10-K income statement, on EDGAR
2. Cash and cash equivalents$1.2M−10% from $1.4M in FY 202010-K balance sheet, on EDGAR
3. Cash from operations−$138KNo year-earlier figure tagged10-K cash flow statement, on EDGAR